Aftermarket brake pads might be compatible with your truck, but they aren't always built to the vehicle manufacturer's ...

You might assume that as long as the pedal goes down and the car eventually stops moving, the brakes are working exactly as the engineers intended. That said, there is a specific failure state called ...

Born from EV technology, this electronic brake booster is quietly transforming how vintage performance cars stop—and why ...

The Detroit Lions are not in a good place right now. They’ve been eliminated from playoff contention, they’re on a three-game losing streak, and they’re currently playing some of the worst football ...

A lottery win is supposed to be the fantasy ending to a regular life—wake up, check your ticket, and suddenly everything changes. That's the dream. But for one self-described "regular Jane who got ...

It’s almost over for the Minnesota Vikings, the finish of a strange season that once showcased Super Bowl hopes but ended in a familiar 8-9 or 9-8 record, depending on the outcome of Week 18.

NEW YORK— Texas Tech forward JT Toppin had a tired smile on his face when he met with reporters in the bowels of Madison Square Garden. His team had just upset an undefeated Duke, battling through ...

Scientists have discovered a way that bacteria in the gut can control genes in our cells. Their work shows that chemical messages from bacteria can alter chemical markers throughout the human genome.

Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia areata, even after the asset narrowly missed the main goal of a midstage ...

Possible health benefits of the inner bark of the slippery elm (Ulmus rubra) tree include managing fevers, treating wounds, and reducing sore throats. Slippery elm is native to the central and eastern ...

Dan Graziano is a senior NFL national reporter for ESPN, covering the entire league and breaking news. Dan also contributes to Get Up, NFL Live, SportsCenter, ESPN Radio, Sunday NFL Countdown and ...

AbbVie ABBV has been consistently increasing its R&D investments to support long-term growth across multiple therapeutic areas. The company’s pipeline spans immunology therapies, expanding oncology ...